CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
efficacy of INO-5401 and INO-9012 in combination with cemiplimab (REGN2810), with radiation and chemotherapy, in subjects with newly-diagnosed glioblastoma...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 20 other locations
Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....
Phase 2, Phase 3
Salt Lake City, Utah, United States and 62 other locations
Optune® together with maintenance TMZ and placebo in newly diagnosed Glioblastoma (GBM) patients. The primary objective of the stud...
Phase 3
Salt Lake City, Utah, United States and 80 other locations
and tolerability of these combinations in adult participants with glioblastoma (GBM). Arm B which was previously added to the proto...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 16 other locations
This research study is studying several investigational drugs as a possible treatment for Glioblastoma (GBM).The drugs involved in ...
Phase 2
Salt Lake City, Utah, United States and 11 other locations
This research study is studying a targeted therapy as a possible treatment for recurrent glioblastoma (GBM).The following intervent...
Phase 2
Salt Lake City, Utah, United States and 6 other locations
are also impermeable to the passage of therapeutic molecules from the blood to the brain. The development of effective treatments against glioblastoma...
Phase 3
Salt Lake City, Utah, United States and 47 other locations
The purpose of this study is to establish the recommended phase 2 dose of eflornithine in combination with temozolomide in patients whose glioblastoma...
Phase 1
Salt Lake City, Utah, United States and 7 other locations
This study will investigate different doses of \[177Lu\]Lu-NeoB in combination with RT and TMZ in participants with newly diagnosed glioblastoma...
Phase 1
Salt Lake City, Utah, United States and 22 other locations
designed to determine the safety and tolerability of a single intratumoral (IT) injection of C5252 in patients with recurrent or progressive glioblastoma...
Phase 1
Salt Lake City, Utah, United States
Clinical trials
Research sites
Resources
Legal